Conference Coverage

VIDEO: RBCs have extended shelf life, randomized trial shows


 

AT ASH 2015

References

ORLANDO – Stored red blood cells kept for longer than a few weeks do not impair outcomes or harm the patients who receive them, Dr. Christine Cserti-Gazdewich reported at the annual meeting of the American Society of Hematology.

In a randomized clinical trial conducted in Kanpala, Uganda, where severe anemia with lactic acidosis is common, children who received RBCs that had been stored from 25-35 days had outcomes that were not inferior to those of children who received RBCs delivered within 10 days of collection. The findings have significant, positive implications for countries and geographic regions where there are chronic shortages of blood products, said Dr. Cserti-Gazdewich, of Toronto General Hospital.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

What’s on tap at ASH 2015
MDedge Hematology and Oncology
ASH: Gene therapy reduces transfusion needs in beta-thalassemia major
MDedge Hematology and Oncology
ASH: Oral drug offers alternative to lifelong transfusions in sickle cell
MDedge Hematology and Oncology
Device linked to anemia in blood donors
MDedge Hematology and Oncology
Risk of anaphylaxis with IV iron products
MDedge Hematology and Oncology
Team characterizes EMH niche
MDedge Hematology and Oncology
Study raises questions about iron dosing
MDedge Hematology and Oncology
Experiment reveals new method of RBC production
MDedge Hematology and Oncology
A new category of cytopenias
MDedge Hematology and Oncology
FDA approves generic imatinib
MDedge Hematology and Oncology